Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use according to the latest Instructions For Use, standalone in the foot and ankle.

Participants needed: 126
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Kuros Biosurgery AGUpdated: Apr 9, 2026Locations: 5
Eligibility criteria

Patient is able to read/be read, understand, and provide written informed consen... [+24]

Read more
Status: Recruiting

Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion

This is a phase IV post-marketing study for MagnetOs Easypack Putty. MagnetOs Easypack Putty is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease or spinal trauma undergoing spinal fusion surgery. In this study, MagnetOs Easypack Putty will be used according to the latest U.S. Instructions For Use, standalone in the posterolateral spine.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kuros Biosurgery AGUpdated: Mar 20, 2026Locations: 6
Eligibility criteria

Patient is able to read/be read, understand, and provide written informed consen... [+8]

Requires > two-level fusion or expected to need secondary intervention within on... [+15]

Read more
Status: Recruiting

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

This is a phase IV post-marketing study for MagnetOs Flex Matrix. MagnetOs Flex Matrix is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease and undergoing spinal fusion surgery. In this study, MagnetOs Flex Matrix will be used according to the latest U.S. Instructions For Use, specifically as a bone graft extender mixed with autograft in a 1:1 vol.% in the posterolateral spine. Trinity Elite will also be used according to its latest IFU approved in the US. Specifically, this cellular based allograft is an allograft intended for the treatment of musculoskeletal defects.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kuros Biosurgery AGUpdated: Feb 25, 2026Locations: 7
Eligibility criteria

Patient is able to read/be read, understand, and provide written informed consen... [+3]

Requires > four-level fusion or expected to need secondary intervention within o... [+15]

Read more